en

PRODUCT DETAIL

Sorafenib Accord 200 mg filmom obalené tablety

Code 2495E
MA number EU/1/22/1696/001
Product Form: tbl flm 112x1x200 mg (blis.Al/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Accord Healthcare S.L.U, Spain
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX02 Sorafenib
Shelf life: 24
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 09.11.2022
Validity: 09.11.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 06.12.2022
eu-flag.png sk-flag.png